This review discusses how a Medical Communications Department can create and maintain new services to internal customers within the pharmaceutical industry. Examples of expanded services that may add value to a Medical Communications Department are listed and described. These new services can increase relationship-building between departments and improve the awareness of the Medical Communications Department's role in the company. However, the new services must be evaluated to ensure that they add value to the department or the company and do not interfere with the performance of core medical information services.
HopkinsFGalligherCLevineA.Medical affairs and drug information practices within the pharmaceutical industry: results of a benchmarking survey. Drug Inf J.1999;33:69–85.
2.
WestD.Pharmaceut Exec.2000;January, 98–106.
3.
PinesWLCottonMNPreparing for an FDA advisory committee meeting. Drug Inf J.1997;31:35–41.
4.
RigginsJLEli Lilly and company global medical information: pharmacy student clerkships in industry. Drug Inf J.1998;32:283–288.
5.
FusAFDrug information clerkships in the pharmaceutical industry. Drug Inf J.1998;32:305–311.
6.
MalechaSEChaAJHoltRJPharmacy student clerkship industry rotation in drug information: the Searle global healthcare resources experience. Drug Inf J.2000;34:91–96.
